Abstract
Aims and objectives: 1. To establish the role of AgNOR in differentiating the benign from the premalignant and the malignant lesions of the prostate. 2. To establish the significance of AgNOR count in differentiating the grades of malignancy. Materials and methods: A prospective study was conducted on 197 prostatic lesions from 2011- 2013. Two sections from each case were stained with haematoxylin and eosin and the other with AgNOR stain. The data was analysed by using SPSS-17.0. Results: The mean AgNOR count of prostatic adenocarcinoma was significantly higher than the benign and premalignant lesions of prostate with P
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
